patient
diphenylhydantoin
weeks
generalized skin rash
lymphadenopathy
pure red cell aplasia
withdrawal
pharmacon
symptoms
spontaneously
Skin rash
complication
diphenylhydantoin
treatment
benign
malignant lymphadenopathy
Pure red cell aplasia
associated with
diphenylhydantoin medication
patients
mechanism
diphenylhydantoin
toxic effects
patient
ingestion
diphenylhydantoin
occurrence
skin rash
lymphadenopathy
pure red cell aplasia
connection
